Julie De Backer - Concepedia

Author

Julie De Backer

Also Known As

B Dumoulin, C Blomström-Lundqvist, DE BACKER J, DE BACKER J, De Backer J, De Backer, Jan, De Backer,Jan, De Paepe, Anne, E Bossone, Ioan Mircea Coman

616

Publications

29.3K

Citations

H-Index

255

Concepts

All Affiliations

Ghent University Hospital Ghent University Antwerp University Hospital Johns Hopkins University KU Leuven

About

Julie De Backer is an author at Ghent University Hospital specializing in medicine, pharmacology, and cardiovascular disease.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	49	117	10.6K
2	Health Sciences	16	19	1.3K
3	Education	11	11	263
4	Engineering	4	4	235
5	Natural Sciences	1	1	78

Julie De Backer

207

Publications

23.8K

Citations

H-Index

Page 1

	Year	Citations
The revised Ghent nosology for the Marfan syndrome: Table 1 Bart Loeys, Harry C. Dietz, Alan C. Braverman, Journal of Medical Genetics	2010	2.2K
2020 ESC Guidelines for the management of adult congenital heart disease Helmut Baumgartner, Julie De Backer, Sonya V. Babu‐Narayan, European Heart Journal	2020	2K
The 2017 international classification of the Ehlers–Danlos syndromes Fransiska Malfait, Clair A. Francomano, Peter H. Byers, American Journal of Medical Genetics Part C Seminars in Medical Genetics	2017	1.8K
A syndrome of altered cardiovascular, craniofacial, neurocognitive and skeletal development caused by mutations in TGFBR1 or TGFBR2 Bart Loeys, Junji Chen, Enid Neptune, Nature Genetics Developmental AnomalyDevelopmental BiologyCraniofacial AnomaliesCraniofacial DevelopmentCongenital Heart Defect	2005	1.8K
Aneurysm Syndromes Caused by Mutations in the TGF-β Receptor Bart Loeys, Ulrike Schwarze, Tammy M. Holm, New England Journal of Medicine	2006	1.6K
2024 ESC Guidelines for the management of peripheral arterial and aortic diseases Lucia Mazzolai, Gisela Teixidó‐Turà, Stefano Lanzi, European Heart Journal	2024	603
Effect of Mutation Type and Location on Clinical Outcome in 1,013 Probands with Marfan Syndrome or Related Phenotypes and FBN1 Mutations: An International Study Laurence Faivre, Gwenaëlle Collod‐Béroud, Bart Loeys, The American Journal of Human Genetics Marfan SyndromeMendelian DisorderGenetic DisorderMedicineGenetics	2007	593
Atenolol versus Losartan in Children and Young Adults with Marfan's Syndrome Ronald V. Lacro, Harry C. Dietz, Lynn A. Sleeper, New England Journal of Medicine	2014	509
Effect of celiprolol on prevention of cardiovascular events in vascular Ehlers-Danlos syndrome: a prospective randomised, open, blinded-endpoints trial Kim-Thanh Ong, Jérôme Perdu, Julie De Backer, The Lancet ThrombosisVascular DiseaseCardiovascular DiseasePharmacologyCardiovascular Pharmacology	2010	401
Mutations in the facilitative glucose transporter GLUT10 alter angiogenesis and cause arterial tortuosity syndrome Paul Coucke, Andy Willaert, Marja W. Wessels, Nature Genetics Metabolic SyndromeArterial Tortuosity SyndromeMolecular PhysiologyAngiogenesisVascular Adaptation	2006	392

Page 1